Pierpaolo Pastina

Siena, 53100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Neurocognitive and neuropsychiatric presentation identifies a higher-risk clinical phenotype in IDH-wildtype glioblastoma: A retrospective cohort study.

Neurocognitive and neuropsychiatric presentation identifies a higher-risk clinical phenotype in IDH-wildtype glioblastoma: A retrospective cohort study.

Journal: Clinical neurology and neurosurgery

Published: July 09, 2026

Reduced Clinical Target Volume Margins in Glioblastoma: Exploratory Evidence Supporting Further Margin Reduction Independent of MGMT Status.

Reduced Clinical Target Volume Margins in Glioblastoma: Exploratory Evidence Supporting Further Margin Reduction Independent of MGMT Status.

Journal: Brain sciences

Published: March 30, 2026

Beyond Resection: Surgery as an Evolutionary Bottleneck Shaping Tumor Evolution and Treatment Response in Diffuse Gliomas.

Beyond Resection: Surgery as an Evolutionary Bottleneck Shaping Tumor Evolution and Treatment Response in Diffuse Gliomas.

Journal: Cancers

Published: February 16, 2026

Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas-prognostic significance in different biological sub-groups.

Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas-prognostic significance in different biological sub-groups.

Journal: Journal of neuro-oncology

Published: July 18, 2025

Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide.

Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide.

Journal: Brain sciences

Published: May 31, 2025

Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol.

Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol.

Journal: Journal of neuro-oncology

Published: September 28, 2024

Correction to: Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.

Correction to: Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.

Journal: Journal of neuro-oncology

Published: September 27, 2024

Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.

Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.

Journal: Journal of neuro-oncology

Published: August 09, 2024

Challenges and Opportunities in Accessing Surgery for Glioblastoma in Low-Middle Income Countries: A Narrative Review.

Challenges and Opportunities in Accessing Surgery for Glioblastoma in Low-Middle Income Countries: A Narrative Review.

Journal: Cancers

Published: July 23, 2024

The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review.

The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review.

Journal: La Radiologia medica

Published: July 19, 2022

Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience.

Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 09, 2022

Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis.

Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis.

Journal: Life (Basel, Switzerland)

Published: September 29, 2021

Showing 1-12 of 45

Last Updated: 09/26/2026